Purpose: To evaluate the association of intimate partner violence (IPV) with breast and cervical cancer screening rates.Methods: We conducted retrospective chart audits of 382 adult women at 4 urban family medicine practices. Inclusion criteria were not being pregnant, no cancer history, and having a partner. Victims were defined as those who screened positive on at least one of 2 brief IPV screening tools: the HITS (Hurt, Insult, Threat, Scream) tool or Women Abuse Screening Tool (short). Logistic regression models were used to examine whether nonvictims, victims of emotional abuse, and victims of physical and/or sexual abuse were up to date for mammograms and Papanicolaou smears. Intimate partner violence (IPV) is an important social concern. It is estimated that 7.7 million IPV victimizations occur each year and that the lifetime prevalence of IPV victimization is 25% among women and 8% among men in the general population.1 Women are particularly vulnerable to the harmful effects of IPV; they are 7 to 14 times more likely than men to suffer severe physical injury from an assault by an intimate partner.2 A history of being the target of violence puts women at increased risk of physical injury, chronic pain syndromes, irritable bowel syndrome, gastrointestinal disorders, sexually transmitted diseases, 3-5 depression, suicide attempts, psychosomatic disorders, reproductive health consequences, and other comorbidities.
6Victims also reported more risky behaviors, including smoking, heavy drinking, and drug use. 1,[7][8][9][10] More recently, research has explored the association between IPV and health issues related to breast and cervical cancer. Studies have found that exposure to IPV increases the risk of cervical cancer, 11,12 possibly through its effect on risk factors such as stress, smoking, and drinking. 11 Alternatively, IPV may be related to decreased adherence to cancer screening. Findings from the few studies about the association between IPV and cancer screening have been inconsistent. A recent Australian study of 7312 middle-aged women (aged 45 to 50) found that those who have experienced IPV